Raymond James & Associates increased its position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 7.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 44,877 shares of the company’s stock after purchasing an additional 2,931 shares during the quarter. Raymond James & Associates’ holdings in BlackRock Health Sciences Trust were worth $1,833,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. International Assets Investment Management LLC purchased a new position in shares of BlackRock Health Sciences Trust during the 4th quarter worth approximately $7,800,000. Wells Fargo & Company MN boosted its position in BlackRock Health Sciences Trust by 10.6% during the fourth quarter. Wells Fargo & Company MN now owns 393,056 shares of the company’s stock worth $15,903,000 after acquiring an additional 37,555 shares during the last quarter. L.M. Kohn & Company grew its stake in BlackRock Health Sciences Trust by 9.9% in the 4th quarter. L.M. Kohn & Company now owns 7,782 shares of the company’s stock worth $315,000 after acquiring an additional 704 shares during the period. Summa Corp. purchased a new position in shares of BlackRock Health Sciences Trust during the 4th quarter worth $528,000. Finally, Janney Montgomery Scott LLC boosted its holdings in shares of BlackRock Health Sciences Trust by 3.2% during the fourth quarter. Janney Montgomery Scott LLC now owns 25,715 shares of the company’s stock worth $1,040,000 after purchasing an additional 809 shares during the last quarter.
BlackRock Health Sciences Trust Stock Down 0.0 %
Shares of NYSE:BME opened at $42.40 on Wednesday. The business has a fifty day simple moving average of $41.27 and a 200-day simple moving average of $40.74. BlackRock Health Sciences Trust has a 52 week low of $35.53 and a 52 week high of $42.86.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- The How and Why of Investing in Gold Stocks
- 3 Small Cap Stocks That Insiders Are Buying
- Ride Out The Recession With These Dividend Kings
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- What is a SEC Filing?
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.